Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Northwest Biotherapeutics (NWBO) Net Long-Term Debt Issued (Repaid) (2009 - 2026)

Updated

Northwest Biotherapeutics (NWBO) reported Net Long-Term Debt Issued (Repaid) of $7.93 million for Q2 2026, up 54.7% from $5.12 million a year earlier and up 13.7% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Net Long-Term Debt Issued (Repaid) (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Northwest Biotherapeutics' Net Long-Term Debt Issued (Repaid) came in at $33.16 million, up 20.8% year-over-year; for FY2025, it came in at $29.99 million, down 8.0% from FY2024.

  • Net Long-Term Debt Issued (Repaid) has a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
  • By year, Net Long-Term Debt Issued (Repaid) came in at $32.58 million in FY2024 (-1.1%), $32.95 million in FY2023, $111,000 in FY2022 (-99.5%) and $23.84 million in FY2021 (+99.3%).
  • Five-year quarterly Net Long-Term Debt Issued (Repaid) spans a low of -$3.41 million in Q1 2022 and a high of $11.72 million in Q4 2024.
  • Year over year, Net Long-Term Debt Issued (Repaid) gained in four of the last eight quarters, with growth averaging 2.1%.
  • The high point for year-over-year Net Long-Term Debt Issued (Repaid) in five years was Q2 2024 (growth of 859.7%); the low point was Q3 2021 (a decline of 84.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $6.97 million (Q1 2026), $11.57 million (Q4 2025) and $6.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Northwest Biotherapeutics 283.78 Mn 273.80 Mn - 7.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.93 Mn
Mar 31, 2026 6.97 Mn
Dec 31, 2025 11.57 Mn
Sep 30, 2025 -2.09 Mn
Jun 30, 2025 -957,000.00
Mar 31, 2025 6.59 Mn
Dec 31, 2024 11.72 Mn
Sep 30, 2024 4.01 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2024 7.10 Mn
Dec 31, 2023 10.47 Mn
Sep 30, 2023 11.55 Mn
Jun 30, 2023 1.04 Mn
Mar 31, 2023 9.90 Mn
Dec 31, 2022 -99,000.00
Sep 30, 2022 4.90 Mn
Jun 30, 2022 -1.29 Mn
Mar 31, 2022 -3.41 Mn
Dec 31, 2021 11.50 Mn
Sep 30, 2021 885,000.00
API Access

Northwest Biotherapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NWBO&period=max&api_key=YOUR_API_KEY